David Burrows
SNC-Lavalin Group Inc.
ATRL-T
TOP PICK
Nov 06, 2024
Very strong portfolio of engineering and design and consulting. Plays into infrastructure, energy, and environment. Focus on nuclear will be important, with 15% of revenue coming from there. If Hwy 407 were sold at a good price, would be a catalyst to create value (but he wouldn't buy something just because there might be a deal down the road). Yield is 0.1%.
He's done 2 legs so far. That's how you should approach a stock, not all in all at once. In an uptrend, resistance coming up. Generally, you don't argue with an uptrend.
Strength in stock price lately. Highly ranked in technical analysis. Owns shares in company, and would recommend buying. Sector out performing with increase in infrastructure spending.
Strong performer over the year. Execution should continue. Got rid of legacy contracts. Strong in civil engineering and nuclear. Could see large growth from nuclear especially, if projects continue to be built.
A lot of action's already happened on this stock. He bought on the breakout, and now there's consolidation. Chart's looking positive, likes the formation, though you may have to live through a bit more consolidation. Yield is 0.1%.
It is going through a turn around recently and de-leveraging the balance sheets. Nuclear energy reactors is a pretty exciting part of the business. He prefers WSP with its M&A activity and design component.
They changed their name, improved productivity and cash flow. They trade at a discount to the group. They have a major nuclear plant projects and many engineering projects in China. People are considering nuclear positively again that will benefit ATRL.
Very strong portfolio of engineering and design and consulting. Plays into infrastructure, energy, and environment. Focus on nuclear will be important, with 15% of revenue coming from there. If Hwy 407 were sold at a good price, would be a catalyst to create value (but he wouldn't buy something just because there might be a deal down the road). Yield is 0.1%.
(Analysts’ price target is $70.31)